CD34 and neoplasm: Next, T-cell proliferation was assessed in co-cultures with effector cells, CD34+ HSCs, unpulsed DCs, or tumor-antigen-pulsed DCs at Effector cell/T cell ratios of 1:1, 1:2, 1:4, and 1:8.